You are here
Potentiating an Anthrax DNA Vaccine with Electroporation
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44AI052670-02
Agency Tracking Number: AI052670
Amount:
$2,634,040.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
6310 NANCY RIDGE DR., STE. 107
SAN DIEGO, CA
92121
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: ALAIN Luxembourg
Phone: (858) 550-2022
Email: ALUXEMBOURG@ICHORMS.COM
Phone: (858) 550-2022
Email: ALUXEMBOURG@ICHORMS.COM
Business Contact
Name: DREW HANNAMAN
Phone: (858) 550-2022
Email: DHANNAMAN@ICHORMS.COM
Phone: (858) 550-2022
Email: DHANNAMAN@ICHORMS.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Anthrax, an infectious disease caused by Bacillus anthracis, became a pressing concern because of its potential biowarfare use, most likely via aerosolized anthrax spore dissemination, resulting in deadly inhalation a
* Information listed above is at the time of submission. *